Virginia Center for Reproductive Medicine (VCRM)
is pleased to share with you our IVF/ICSI results from January
1 - December 31, 2004. Our success rates continue to be well above
the national average success rate (see Table below). Since August
2003, we have implemented the use of blastocyst (day 5) transfer
for the vast majority of our patients (mean 2.3), and restricted
the number of embryos transferred to 2 in most cases (only two
triplet pregnancies were noted ). Our other results such as donor
egg (57% ongoing pregnancy rate), and frozen embryo cycles (20.0%
ongoing pregnancy rate) as also available on our website.
|
IVF/ICSI
|
|
|
|
|
|
Number of cycles
|
|
|
|
|
|
Number of Transfers
|
|
|
|
|
|
Cancellation rate
(%)
|
|
|
|
|
|
Clinical Pregnancies
(%)
|
|
|
|
|
|
Miscarriage Rate
(%)
|
|
|
|
|
At VCRM, we have initiated our Egg
Freezing program more than 2 years ago. The program is
intended mainly for women who desire to store some of their eggs
when relatively young (< 35) if they have no immediate plans
to start a family and are worried about the impact of aging on
egg quality and number. This program is also available to women
recently diagnosed with cancer, before undergoing chemotherapy
or radiation treatment. There has been more
than 150 deliveries from frozen eggs in the world, with
no increase in genetic or developmental abnormalities in the resulting
children. For more information, please visit our website or call
703-437-7722 to schedule an
appointment.
In an attempt to circumvent the expensive nature
of assisted reproduction, we have been offering our IVF refund
plan and Donor Egg Refund Plan for eligible patients who do not
have insurance coverage for ART for over a year. This program
now offers eligible patients up to
seven (7) fresh IVF or donor egg cycles, including cryopreservation
of resulting embryos. If there is no live birth after the transfer
of all the fresh and frozen embryos from these 7 cycles, patients
will have 100% of their money
back to pursue other options such as adoption. We feel so confident
in our superior rates that we are willing to offer such a program
to our qualifying patients. For more information please refer
to our website at www.vcrmed.com,
or call our office at 703-437-7722
for a consultation.
In contrast to healthy men whose sperm continuously divide and renew themselves well into later life, healthy women are born with all the eggs that they will ever have. A female fetus contains approximately seven million eggs, but by the time that fetus has become a baby girl and is born, the number of eggs in her ovaries is down to between one and two million. By puberty, a normal girl will have lost all but 400,000 of those eggs, and she will continue, throughout her adult life, to lose approximately 1,000 eggs each month. Although a woman's reproductive age may not correspond to her biological age, women are most fertile when they are younger (late teens and twenties) making getting pregnant more difficult by the mid-to-late 30s. To date, the most specific and important test to measure ovarian reserve is the measurement of ovarian volume and antral follicle counts as measured on transvaginal ultrasound. The ultrasound is performed using a vaginal probe on the third day of the patient's menses. Both ovaries are examined, measured in three dimensions, and the small follicles in each ovary are then counted. Women with small ovarian volumes and fewer than five follicles per ovary are much more likely to have an earlier menopause and have a much higher incidence of failed treatment cycles. In contrast, women whose ovaries are determined to be larger than average and have more than five follicles per ovary are likely to have a later menopause. The daily application of this test at VCRM has enabled many women to move aggressively with treatment once their ovaries have been noted to be compromised, and therefore avoid losing very precious time. It is important to note that small ovarian volumes and low antral follicle counts have been seen in all age groups, and therefore being young should not be a reason to delay this very important but simple and non invasive test.
In an effort to decrease the high incidence
of multiple pregnancy with ART, we have begun offering the transfer
of a single embryo transfer (SET) for couples who do not want
to, or have medical contraindications to carrying a twin pregnancy.
For the last 9 months, only 10 women agreed to a SET and all conceived
(9/10 are ongoing). The biggest
obstacle facing us has been patient acceptance. A large majority
of our patients (80%) want twins, and most couples are resistant
to accepting SET for now. We have devised new strategies to increase
patient acceptance for this cutting edge procedure.
Recent published data, including our own, and data presented at
the last ASRM meeting last October are very encouraging; and show
a pregnancy rate (PR) of 50-80% with SET. SET is increasingly
the norm in Australia, Belgium, and some Scandinavian countries
where SET accounts for 50-75% of all transfers, and is currently
enforced in women < 38 in Sweden. Belgium is likely to follow
suit.
Currently in the US, over 60% of the population
is overweight (BMI > 25) and 30% are obese (BMI > 30). The
negative effects of both being underweight (BMI < 19) and overweight/obese
on pregnancy rates have been proven in multiple studies, including
our own that we published in 2001. In our study, the pregnancy
rates were decreased by 50%
when the BMI is > 25 compared to normal weight women. The same
results are noted when IUI is performed. It is imperative that
women contemplating pregnancy be informed of the significantly
negative impact of being over/underweight on their odds at getting
pregnant.